The Public-Private Mix (PPM) TB project is a two–year grant (January 2019 - December 2020) from the Global Fund (GF) aimed at increasing private sector contribution in TB case-finding. Caritas Nigeria is a Sub – Recipient to the Institute of Human Virology Nigeria (IHVN) who is the Principal Recipient (PR) for the grant.

The project specifically aims at increasing private sector contribution in finding more people needing tuberculosis treatment from 11% in 2017 to 35% in 2020. 

PPM TB project targets the general public for TB screening, identification of TB suspects, Sputum samples collection from TB suspects for laboratory analysis using Gene Xpert technology, treatment and follows–up of TB infected cases.

 CCFN is working to achieve the project goals in twenty states namely Edo, Delta, Cross River, Akwa Ibom, Benue and Oyo. Others are Ondo, Osun, Ogun, Kogi, Niger, Sokoto, Plateau, Nasarawa, Kaduna, Anambra, Enugu, Rivers, Imo and  Abia.

The FBO health facilities are supported to engage in community outreaches to identify TB suspects for diagnosis, treatment and follow–up.

{snippet ppm-objectives}



Health Spotlight

Monday, 27 March 2023 10:28

The Caritas Nigeria team on the 24th March 2023 with representatives of some public health partners in the state and at her headquarter located in Abuja, collaborated with the State Ministry of...

Galvanizing Religious Leaders for Accelerated Identification & Linkage to Pediatric ART (GRAIL) Project is a Congregational-based approach to promoting Early Diagnosis and Treatment for Children...

Tuesday, 10 January 2023 01:17

Caritas Nigeria is passionately committed to improving the health and socio-economic outcomes of children who are orphaned by, infected with, or at risk of HIV, along with their households. We...

Monday, 31 October 2022 19:11

The United State- Centers for Disease Control and Prevention (US-CDC) on Thursday 27 October awarded the Enugu State Government with an award of excellence for her leadership role in the...

Monday, 31 October 2022 14:21

Read Also

Sorry, this website uses features that your browser doesn’t support. Upgrade to a newer version of Firefox, Chrome, Safari, or Edge and you’ll be all set.